» Authors » Daniel Schembri Wismayer

Daniel Schembri Wismayer

Explore the profile of Daniel Schembri Wismayer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 13
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Schembri Wismayer D, Laurenti M, Song Y, Egan A, Welch A, Bailey K, et al.
Am J Physiol Endocrinol Metab . 2023 Jun; 325(2):E119-E131. PMID: 37285600
Elevated fasting free fatty acids (FFAs) and fasting glucose are additively associated with impaired glucose tolerance (IGT) and decreased β-cell function [quantified as disposition index (DI)]. We sought to examine...
2.
Kohlenberg J, Laurenti M, Egan A, Schembri Wismayer D, Bailey K, Cobelli C, et al.
Diabetologia . 2022 Sep; 66(1):201-212. PMID: 36112169
Aims/hypothesis: People with isolated impaired fasting glucose (IFG) have normal beta cell function. We hypothesised that an increased glucose threshold for beta cell secretion explains IFG. Methods: We used graded...
3.
Adams J, Egan A, Laurenti M, Schembri Wismayer D, Bailey K, Cobelli C, et al.
Metab Syndr Relat Disord . 2022 Apr; 20(6):329-335. PMID: 35442800
The rs7903146 variant in the gene is associated with defects in postprandial insulin and glucagon secretion and increased risk of type 2 diabetes. However, it is unclear if this variant...
4.
Adams J, Egan A, Laurenti M, Schembri Wismayer D, Bailey K, Cobelli C, et al.
Am J Physiol Endocrinol Metab . 2021 Oct; 321(5):E728-E736. PMID: 34658253
Type 2 diabetes is a disease characterized by impaired insulin secretion and defective glucagon suppression in the postprandial period. We examined the effect of impaired glucagon suppression on glucose concentrations...